Papadopoulos, Kyriakos P, Taofeek K Owonikoko, Melissa L Johnson, Irene Brana, Marta Gil-Martin, Raymond P Perez, Victor Moreno, April K Salama, Emiliano Calvo, Nelson S Yee, Howard Safran, Antonio Gonzalez-Martin, Raid Aljumaily, Daruka Mahadevan, Kosalai K Mohan, Jingjin Li, Elizabeth Stankevich, Israel Lowy, Matthew G Fury, and Jade Homsi. “Cemiplimab (REGN2810), a Fully Human Anti-PD-1 Monoclonal Antibody, for Patients With Unresectable Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: Initial Safety and Efficacy from Expansion Cohorts of Phase 1 Study”. SKIN The Journal of Cutaneous Medicine 2, no. S1 (February 23, 2018): S45. Accessed March 28, 2024. https://www.jofskin.org/index.php/skin/article/view/301.